Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 5, 2021
Reporting Period: Second Quarter 2021
Context: This filing serves to disclose the Company's second quarter 2021 financial results via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The actual revenue, profit, cash flow, margins, debt, and liquidity figures are contained within the referenced press release (Exhibit 99.1), which is not included in the input text. Therefore, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes versus the prior comparable period are detailed in the provided text. The document solely announces the issuance of the Q2 2021 results.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued on August 5, 2021, containing the financial results.
Legal Status of Information: The information in the press release and Item 2.02 is "furnished" rather than "filed" under Section 18 of the Exchange Act. Consequently, it is not subject to liability under that section and is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are listed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 5, 2021) for actual Q2 2021 financial figures.
- Verify the specific revenue and net loss numbers, as they are not present in the 8-K cover sheet.
- Confirm cash position and burn rate details from the full press release.
- Check for any forward-looking statements or guidance included in the press release.